{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-122587","form_type":"8-K","ticker":"BTAI","cik":"0001720893","company_name":"BioXcel Therapeutics, Inc.","filed_at":"2024-11-25T23:59:59+00:00","discovered_at":"2026-05-14T18:03:09.359682+00:00","generated_at":"2026-05-29T19:01:18.474654+00:00","sec_items":["1.01","9.01"],"event_type":"other_material","sentiment":"negative","materiality_score":0.8,"calibrated_materiality_score":0.8,"confidence":"high","headline":"BioXcel raises ~$6.2M in public offering of stock and warrants; cash runway into Q1 2025","bullets":["Issued 5.6M shares and warrants, plus 9M pre-funded warrants, at $0.48 per share (or $0.479 for pre-funded).","Net proceeds of ~$6.2M after underwriting discounts; use for SERENITY At-Home and TRANQUILITY In-Care trials.","Cash runway expected into Q1 2025 when combined with existing cash; potential need for additional capital.","Exercise price of 8.5M previously issued warrants reduced to $0.571 per share on Nov 21, 2024."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-122587","json":"https://secwatch.observer/filing/0001104659-24-122587.json","markdown":"https://secwatch.observer/filing/0001104659-24-122587.md","text":"https://secwatch.observer/filing/0001104659-24-122587.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1720893/000110465924122587/0001104659-24-122587-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1720893/000110465924122587/tm2428677d4_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-29T19:01:18.474654+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}